Company No:
Contents
Note | 30.06.2023 | 30.06.2022 | ||
€ | € | |||
Fixed assets | ||||
Investments | 3 |
|
|
|
589 | 589 | |||
Current assets | ||||
Debtors | 4 |
|
|
|
80,569 | 112,724 | |||
Creditors: amounts falling due within one year | 5 | (
|
(
|
|
Net current liabilities | (44,468) | (43,549) | ||
Total assets less current liabilities | (43,879) | (42,960) | ||
Net liabilities | (
|
(
|
||
Capital and reserves | ||||
Called-up share capital | 6 |
|
|
|
Profit and loss account | (
|
(
|
||
Total shareholder's deficit | (
|
(
|
Director's responsibilities:
The financial statements of AOST Group Limited (registered number:
Dr Trudy Pisani
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.
AOST Group Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2nd Floor Stratus House Emperor Way, Exeter Business Park, Exeter, EX1 3QS, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in EUR which is the functional currency of the Company and rounded to the nearest €.
In 2023 the directors made the decision that the Company would cease trading. The transfer was finalised in March 2023. As a result the financial statements have been prepared on a basis other than the going concern.
Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Year ended 30.06.2023 |
Period from 01.01.2021 to 30.06.2022 |
||
Number | Number | ||
Monthly average number of persons employed by the Company during the year, including the director |
|
|
Investments in subsidiaries
30.06.2023 | |
€ | |
Cost | |
At 01 July 2022 |
|
At 30 June 2023 |
|
Carrying value at 30 June 2023 |
|
Carrying value at 30 June 2022 |
|
30.06.2023 | 30.06.2022 | ||
€ | € | ||
Amounts owed by Group undertakings |
|
|
|
Other debtors |
|
|
|
|
|
30.06.2023 | 30.06.2022 | ||
€ | € | ||
Trade creditors |
|
|
|
Amounts owed to Group undertakings |
|
|
|
Accruals |
|
|
|
|
|
30.06.2023 | 30.06.2022 | ||
€ | € | ||
Allotted, called-up and fully-paid | |||
|
|
|
Other related party transactions
30.06.2023 | 30.06.2022 | ||
€ | € | ||
Amounts owed (to)/by subsidiary | (125,037) | 112,724 | |
Amounts owed by companies under common control | 80,569 | 0 |